Markets:

Overview

News

Currencies

International

Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

15.88 +0.03 (+0.19%)

Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Personalis, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Personalis Forms Research Collaboration to Better Predict Immunotherapy Response for Gastroesophageal Cancer

October 04, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

August 30, 2022

From Personalis, Inc.

Via Business Wire

Personalis Adds New MRD Patent Covering the Combination of Tumor-Informed and Database-Derived Content to Patent Infringement Complaint Against Foresight Diagnostics

August 17, 2022

From Personalis, Inc.

Via Business Wire

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 16, 2022

From Personalis, Inc.

Via Business Wire

Expert Ratings for Personalis ↗

May 05, 2022

Personalis (NASDAQ:PSNL) has observed the following analyst ratings within the last quarter:

Via Benzinga

Personalis: Q4 Earnings Insights ↗

February 24, 2022

Personalis (NASDAQ:PSNL) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Personalis in Partnership with BC Cancer to Assess Clinical and Economic Benefits of ctDNA for Colorectal and Pancreatic Cancers

August 15, 2022

From Personalis, Inc.

Via Business Wire

5 Top Stocks Cathie Wood Bought This Week ↗

August 05, 2022

Cathie Wood continues to increase positions in some of her top stocks despite recession fears. She bought names like EXAS and PACB this week.

Via InvestorPlace

Personalis to Participate at the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference

August 04, 2022

From Personalis, Inc.

Via Business Wire

Personalis: Q2 Earnings Insights ↗

August 03, 2022

Personalis (NASDAQ:PSNL) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Personalis beat estimated...

Via Benzinga

Personalis Reports Second Quarter 2022 Financial Results

August 03, 2022

From Personalis, Inc.

Via Business Wire

Personalis Files Patent Infringement Lawsuit Against Foresight Diagnostics

August 02, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Announce Second Quarter 2022 Financial Results

July 20, 2022

From Personalis, Inc.

Via Business Wire

Personalis Announces Expansion of Its Patent Portfolio Related to Tumor-Informed Detection of Molecular Residual Disease

July 12, 2022

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

Personalis Reports First Quarter 2022 Financial Results

May 04, 2022

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Personalis to Present at Upcoming Investor Conferences

April 28, 2022

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

May 05, 2022

During Thursday, 351 stocks hit new 52-week lows.

Via Benzinga

Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma

April 26, 2022

From Personalis

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic Sales

April 21, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Announce First Quarter 2022 Financial Results

April 20, 2022

From Personalis, Inc.

Via Business Wire

Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene

April 12, 2022

From Personalis, Inc.

Via Business Wire

Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform

April 12, 2022

From Personalis, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Personalis and Merck KGaA, Darmstadt, Germany to Present Comprehensive Tumor Subtyping Collaboration Data at AACR Annual Meeting 2022

April 11, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Present at the 21st Annual Needham Virtual Healthcare Conference

March 31, 2022

From Personalis, Inc.

Via Business Wire

Diagnostic Industry Veteran Karin Eastham to Chair Personalis Board of Directors

March 24, 2022

From Personalis, Inc.

Via Business Wire

Personalis to Present Data Demonstrating Breadth of NeXT Platform for Oncology at AACR Annual Meeting 2022

March 23, 2022

From Personalis, Inc.

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.